#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peritoneal neoplasm Acute lymphocytic leukaemia Systemic candida Immune thrombocytopenia Juvenile psoriatic arthritis Rheumatoid arthritis Neuropathy peripheral Rhabdoid tumour Glycogen storage disease type II Red blood cell abnormality Tourette's disorder Bone marrow disorder Paget's disease of the vulva Epidermolysis bullosa NTRK gene fusion overexpression More trials…

    Learn about Rare Diseases

    Haemophilia – Basic Information Retinitis pigmentosa – Basic Information Osteosarcoma metastatic – Treatment Adrenogenital syndrome Bronchiolitis obliterans syndrome – Life with Disease Breast angiosarcoma metastatic – Life with Disease Inclusion body myositis – Basic Information Small intestine leiomyosarcoma Nodal marginal zone B-cell lymphoma Angiosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cldn6 Rna-Lpx Fludarabine Phosphate Aficamten Oxaliplatin Apremilast Lomustine Imipenem Tub-040 Vamorolone Rgx-202 Mirabegron Bt8009 Human Immunoglobulin G Pyridoxine Hydrochloride Soya Oil, Purified Benzocaine At-1501 Dermatophagoides Farinae ZIGAKIBART Gadoteric Acid More therapies…

    Learn about Your Condition

    Post cardiac arrest syndrome Epithelioid sarcoma Colon cancer metastatic Acquired haemophilia Skin neoplasm excision Thyroid mass Mucopolysaccharidosis Vesicoureteric reflux Diabetic foot Sarcoma Retinal artery occlusion Streptococcal infection Spina bifida Skin bacterial infection Osteosarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Polycystic ovarian syndrome

  • Study on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    • Obesity
    • Overweight
    Investigated Drugs:
    • Medroxyprogesterone Acetate
    • Dydrogesterone
    • Glucose
    Germany
  • Study on Acupuncture and Metformin for Improving Insulin Sensitivity in Women with Polycystic Ovary Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Metformin Hydrochloride
    Sweden
  • Study on Letrozole and Gonadotropins for Women with Polycystic Ovary Syndrome (PCOS) to Improve Live Birth Rates

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Follitropin Alfa
    • HUMAN MENOPAUSAL GONADOTROPHINS
    • Letrozole
    The Netherlands
  • Study on Pregnancy Rates in Women with Polycystic Ovary Syndrome Using Letrozole and Gonadotropins

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Follitropin Alfa
    • Follitropin Alfa (Genetical Recombination)
    • Follitropin Beta
    Spain
  • Study on Metformin and Metformin Hydrochloride for Overweight Adults with Polycystic Ovary Syndrome

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Metformin
    • Metformin Hydrochloride
    Finland
  • Study on the Effects of Spironolactone, Pioglitazone, and Metformin for Adolescent Girls and Young Women with Polycystic Ovary Syndrome (PCOS)

    Not recruiting

    2 1
    Investigated Drugs:
    • Metformin
    • Pioglitazone
    • Spironolactone
    Austria Denmark Italy Norway Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!